“…The main reason for a high efficacy of pamidronate is that it acts directly on bone tissue, therefore, the local use of pamidronate provides regulation of the secretion of various serum bone turnover markers, growth factors, or cytokines, such as osteprotegrin (OPG), receptor activator of NF-κB ligand (RANKL), and tumour necrosis factor (TNF-α). In previous in vivo studies, where the BP-enriched bone cement was implanted into the tibia of rats, it was revealed that local use of pamidronate led to an increase in the quality of bone density, improved bones' microstructure, and might have had an influence on some bones' turnover markers (20,21). Therefore, such findings might have an important effect on bone implant osteointegration in the prevention of bone collapse and also in the enhancement of implant fixation (8,25).…”